Colloidal Bismuth Subcitrate
Description
Colloidal Bismuth Subcitrate is used to treat ulcers in the stomach and intestines. It is also be used in combination with other medicines for the treatment of Helicobacter pylori infections.
QUICK LINKS:
Side effects
Major & minor side effects for Colloidal Bismuth Subcitrate
- Bone and joint pain
- Nausea and Vomiting
- Dark stools
- Darkening of tongue
Uses of Colloidal Bismuth Subcitrate
What is it prescribed for?
- Gastric and duodenal ulceration
- Helicobacter pylori Infection
Read More
Concerns
Commonly asked questions
- Onset of actionThe amount of time required for this medicine to show its action is not clinically established.
- Duration of effectThe amount of time for which this medicine remains active in the body is not clinically established.
- Safe with alcohol?Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
- Is it habit forming?No habit-forming tendencies were reported.
- Usage in pregnancy?This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
- Usage while breast-feeding?This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
Moderate to Severe Renal impairment
This medicine is not recommended for use in patients with moderate to severe kidney impairment due to the risk of adverse effects.
Allergy
This medicine is not recommended for use if you have a known allergy to colloidal bismuth subcitrate or any other inactive ingredients present along with it.
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings
Other medicines
Colloidal Bismuth Subcitrate may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.
Kidney impairment
This medicine should be used with caution in patients with mild kidney impairment due to the increased risk of worsening of the patient's condition. Close monitoring of kidney function, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition. This medicine is not recommended for use in patients with moderate to severe kidney impairment due to the risk of adverse effects.
Missed Dose
Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions
Disease
Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as advised by the doctor. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Do not stop taking the medicine before completion of the course/without consulting your doctor.
Miscelleneous
How it works
This medicine works by neutralizing the acid produced in the stomach. It also interferes with certain processes that are necessary for the growth of bacteria.
Legal Status
Classification
Category
Antireflux agents & antiulcerants, Antacids
Schedule
Schedule H
[Internet]. Drugbank.ca. 2019 [cited 8 January 2019]. Available from:
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2019 [cited 13 May 2019]. Available from:
The mode of action of colloidal bismuth subcitrate. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2019 [cited 13 May 2019]. Available from:
Information on this page was last updated on 13 May 2019
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.